Agenda

The rising tide of antimicrobial resistance - a high price to pay

An INEOS Oxford Institute for Antimicrobial Research - Oxford Martin School event to mark World Antimicrobial Awareness Week 2022

Friday, 18 November 2022

Lecture Theatre, Oxford Martin School, 34 Broad Street, OX1 3BD, Oxford

Agenda

9:00 Registration with tea & coffee

Session 1: AMR burden and scale of threat

Chair: Prof. Chas Bountra, Pro-Vice Chancellor for Innovation and Professor of Translational Medicine, University of Oxford

9:30 Opening remarks from the Chair

9:35 Stopping the unthinkable becoming the inevitable
Sir Jim Ratcliffe, Chairman, INEOS

9:45 AMR: A public health concern in need of an orchestrated response
Prof. Hanan Balkhy, Assistant Director-General for the Antimicrobial Resistance Division, World Health Organization

10:15 ReAct perspective on progress and barriers to manage the AMR challenge
Prof. Otto Cars, Founder and Senior Strategic Advisor, ReAct

10:30 The global burden of AMR - lessons learnt and opportunities for AMR mitigation
Dr. Janet Midega, Senior Research Manager - Drug-Resistant Infections, Wellcome

10:45 A surgical perspective on AMR
Prof. Neil Mortensen, Professor of Colorectal Surgery, University of Oxford, and President of the Royal College of Surgeons of England

11:00-11.30 Panel session: patient perspectives and global responses
Arlene Brailey (Patient Support Officer, ANTRUK), Prof. Hanan Balkhy, Prof. Otto Cars, Prof. Neil Mortensen, Dr. Janet Midega

11:30-12:00 Tea and coffee break

Session 2: Economic perspectives

Chair: Prof. Sir Charles Godfray, Oxford Martin School Director, University of Oxford

12:00 Economic Perspectives on AMR: where are we now?
Jim O’Neill, The Lord O’Neill of Gatley

12:15 Making the challenging case for AMR investment in low-income countries
Dr. Catriona Waddington, Chair, Expert Advisory Group, Fleming Fund (Mott MacDonald, Management Agents)

12:30 Quantifying the economic cost of AMR
Dr. Julie Robotham, Head of Modelling and Evaluation for Healthcare Associated Infections and Antimicrobial Resistance, UK Health Security Agency

12:45 The economic challenges of tackling AMR through innovation
Dr. Laurence Roope, Senior Researcher, Health Economics Research Centre, University of Oxford

13:00 Building the Investment and Economic case for AMR: Perspectives from Responsible Investment
Anita McBain, Managing Director | Head of Europe, Middle East and Africa Environmental, Social and Governance Research, Citi Research

13:15 Closing comments from the Chair

13:20 Meeting closed

13.30 Lunch, Balliol College (Oxford)